tlooto
Sign up
Sulfur Compounds in BiologyClinical Nutrition and GastroenterologyHeart Failure Treatment and Management

Additional therapeutic benefits of H2S-Donor combined with Dapagliflozin in a model of heart failure with preserved ejection fraction (HFpEF)

M. Riemma, E. Mele, M. Donniacuo, V. Vellecco, M. Telesca, D. Cappetta, M. Bucci, K. Urbanek, F. Rossi, L. Berrino, A. De Angelis

2026.6.1VASCULAR PHARMACOLOGY

DOI: 10.1016/j.vph.2026.107642

Abstract

Abstract is not available.

Citation format

RIEMMA, M., et al. Additional therapeutic benefits of h2s-donor combined with dapagliflozin in a model of heart failure with preserved ejection fraction (hfpef). VASCULAR PHARMACOLOGY, 2026, 163: 107642.